Review

Glutamate Transporter Activators as Anti-Nociceptive Agents

Volume 43 · Issue 3 · January 2011 Publish Date: September 3, 2019
Full Text PDF
DOI
Robert L. Stephens Jr.
Department of Physiology and Cell Biology
Stephens Jr., R. L. (2019). Glutamate Transporter Activators as Anti-Nociceptive Agents. The Eurasian Journal of Medicine, 43(3), 182–185. https://doi.org/10.5152/eajm.2011.39
Full Text Full Text PDF

Abstract

Abstract

The effective management of chronic pain remains enigmatic. There is a paucity of effective mechanistically-based approaches employed. Chronic visceral pain is a particularly difficult subcategory to manage. Glutamate is the most predominant excitatory neurotransmitter and mediates many aspects of sensory function including acute and chronic pain. There is a growing literature describing the efficacy of physiologically dominant glutamate transporter GLT-1 up-regulation in attenuating chronic visceral and somatic nociception. Since glutamate is the major excitatory neurotransmitter released in the first central synapse of the pain-transmitting afferent neurons, augmentation of GLT-1 activity, which reduces extracellular levels of glutamate, may be an important target for pain management strategies. This review summarizes studies in our laboratory and others which highlight findings that GLT-1 up-regulation by transgenic, pharmacologic and viral transfection approaches attenuate a host of nociceptive responses emanating from visceral or somatic sources in animal models. The study also outlines the future work that will be required to ascertain the translational potential of this approach.

Similar Articles

Article Info
Published In
Journal The Eurasian Journal of Medicine
Volume / Issue Volume 43 · Issue 3 · January 2011
Pages 182-185
History
Published Online September 3, 2019
Copyright
Affiliations
Robert L. Stephens Jr.
Department of Physiology and Cell Biology
Cite this Article
Stephens Jr., R. L. (2019). Glutamate Transporter Activators as Anti-Nociceptive Agents. The Eurasian Journal of Medicine, 43(3), 182–185. https://doi.org/10.5152/eajm.2011.39
Outlines